sample	tissue	condition	fpkm
SRR516129	skin	male and 5 month	2.20641
SRR516128	skin	male and 5 month	1.8445900000000002
SRR516135	skin	male and 5 month	1.7107700000000001
SRR516126	skin	male and 5 month	1.51007
SRR516123	skin	male and 3.5 year	1.38436
SRR516121	skin	male and 3.5 year	1.3383
SRR516127	skin	male and 5 month	1.30389
SRR516131	skin	male and 5 month	1.25138
SRR516132	skin	male and 5 month	1.15657
SRR1562528	eye	normal	0.942421
SRR516125	skin	male and 3.5 year	0.800367
SRR1299127	caudal fin	Two days time after treatment	0.707426
SRR516124	skin	male and 3.5 year	0.693501
SRR1299124	caudal fin	Zero day time after treatment	0.6433300000000001
SRR516133	skin	male and 5 month	0.599735
SRR516134	skin	male and 5 month	0.56265
SRR1299125	caudal fin	Half day time after treatment	0.516604
SRR1299126	caudal fin	One day time after treatment	0.501792
SRR1299129	caudal fin	Seven days time after treatment	0.47246400000000005
SRR516122	skin	male and 3.5 year	0.324707
SRR1299128	caudal fin	Three days time after treatment	0.31022
SRR941749	anterior pectoral fin	normal	0.22791
SRR891512	blood	normal	0.182973
SRR1562531	muscle	normal	0.168594
SRR941753	posterior pectoral fin	normal	0.153048
SRR516130	skin	male and 5 month	0.0975737
SRR1205160	5dpf	transgenic sqET20 and GFP+	0.0737114
SRR800046	sphere stage	5azaCyD treatment	0.065157
SRR1205169	5dpf	transgenic sqET20 and neomycin treated 5h and GFP+	0.0535328
SRR1342219	embryo	marco morpholino and infection with Mycobacterium marinum	0.0511988
SRR1205163	5dpf	transgenic sqET20 and neomycin treated 3h and GFP+	0.045292900000000004
SRR527834	head	normal	0.0426721
SRR1021215	sphere stage	Mzeomesa	0.0424487
SRR038627	embryo	control morpholino	0.03907290000000001
SRR527833	5 dpf	normal	0.0387759
SRR1562533	testis	normal	0.0371805
SRR1562529	intestine and pancreas	normal	0.0326349
SRR633544	larvae	exposed to cold stress	0.0301048
SRR592699	pineal gland	normal	0.0285395
SRR1562532	spleen	normal	0.026629900000000005
SRR1021213	sphere stage	normal	0.0251553
SRR592703	pineal gland	normal	0.0228592
SRR1534350	larvae	5 ug/l BDE47 treatment	0.0227217
SRR594771	endothelium	normal	0.022311
SRR633516	larvae	normal	0.0221072
SRR797914	embryo	pbx2/4-MO	0.0213655
SRR372798	28 hpf	normal	0.0205857
SRR630464	5 dpf	injected epidermidis	0.0197389
SRR633550	larvae	exposed to hypoxia stress	0.0178135
SRR749515	24 hpf	eif3ha morphant	0.017078799999999998
SRR1167752	embryo	normal	0.0163952
SRR797917	embryo	pbx2/4-MO and prdm1-/-	0.0162893
SRR1167763	embryo	ptpn6 morpholino and bacterial infection	0.014381399999999999
SRR1188148	embryo	Control PBS 0.5 hpi	0.0138917
SRR372793	shield	normal	0.013087399999999999
SRR1205157	5dpf	transgenic sqET20 and neomycin treated 1h and GFP+	0.0113396
SRR592702	pineal gland	normal	0.011323399999999999
SRR527844	24hpf	normal	0.011280799999999999
ERR594418	retina	transgenic flk1 and develop tumors	0.010760200000000001
SRR1523214	embryo	glut12 morpholino	0.00979083
SRR797911	embryo	prdm1-/-	0.00951919
SRR658547	6 somite	Gata5/6 morphant	0.00930151
SRR658533	bud	normal	0.00900491
SRR519727	6 dpf	FETOH treatment	0.00857145
SRR372796	bud	normal	0.00782472
SRR514028	retina	control morpholino	0.00779834
SRR519737	2 dpf	VD3 treatment	0.00711437
SRR372800	2 dpf	normal	0.00691906
SRR519732	7 dpf	FETOH treatment	0.00620322
SRR1205154	5dpf	transgenic sqET20	0.00573449
SRR372791	dome	normal	0.00566441
SRR519717	2 dpf	FETOH treatment	0.00535537
SRR797908	embryo	normal	0.00502741
SRR519722	4 dpf	FETOH treatment	0.00329844
SRR519742	4 dpf	VD3 treatment	0.00291127
SRR519752	7 dpf	VD3 treatment	0.00250266
SRR519747	6 dpf	VD3 treatment	0.00207879